Zusammenfassung
Spätestens seit der Entdeckung der Rolle des Komplementfaktor-H- (CFH-) Polymorphismus bei der altersabhängigen Makuladegeneration (AMD) scheint eine Beteiligung des Komplementsystems an der Pathogenese dieser Erkrankung gesichert. Das Komplementsystem gehört zum unspezifischen Abwehrsystem und ist eng mit zellulären Immunantworten und dem spezifischen Abwehrsystem verknüpft. Anhand der derzeitigen Datenlage soll hier eine Übersicht über das Komplementsystem und mögliche immunpathogenetische Vorgänge bei der AMD gegeben werden.
Abstract
The discovery of the complement factor H (CFH) polymorphism in age-related macular degeneration (AMD) strongly suggests a causative role of the complement system in the pathogenesis of this disease. The complement system is part of the innate immune system and is closely associated with the cellular response and the adaptive immune system. This article provides an overview of the complement system and, taking the new data into account, of possible immunopathogenetic processes in AMD.
Literatur
Alper CA (1987) Inherited deficiencies of complement components in man. Immunol Lett 14:175–181
Ambati J, Ambati BK, Yoo SH, Ianchulev S, Adamis AP (2003) Age-related macular degeneration: etiology, pathogenesis, and therapeutic strategies. Surv Ophthalmol 48:257–293
Anderson DH, Mullins RF, Hageman GS, Johnson LV (2002) A role for local inflammation in the formation of drusen in the aging eye. Am J Ophthalmol 134:411–431
Bitter-Suermann D (1983) Das Komplementsystem: Physiologische Funktion und klinische Bedeutung. Dtsch Ärztebl 33–48
Bok D (2005) Evidence for an inflammatory process in age-related macular degeneration gains new support. Proc Natl Acad Sci USA 102:7053–7054
Bora NS, Gobleman CL, Atkinson JP, Pepose JS, Kaplan HJ (1993) Differential expression of the complement regulatory proteins in the human eye. Invest Ophthalmol Vis Sci 34:3579–3584
Conley YP, Thalamuthu A, Jakobsdottir J, Weeks DE, Mah T, Ferrell RE, Gorin MB (2005) Candidate gene analysis suggests a role for fatty acid biosynthesis and regulation of the complement system in the etiology of age-related maculopathy. Hum Mol Genet, im Druck
Crabb JW, Miyagi M, Gu X et al. (2002) Drusen proteome analysis: an approach to the etiology of age-related macular degeneration. Proc Natl Acad Sci USA 99:14682–14687
Edwards AO, Ritter R, Abel KJ, Manning A, Panhuysen C, Farrer LA (2005) Complement factor H polymorphism and age-related macular degeneration. Science 308:421–424
Evans JR (2001) Risk factors for age-related macular degeneration. Prog Retin Eye Res 20:227–253
Gotze O, Muller-Eberhard HJ (1972) Paroxysmal nocturnal hemoglobinuria. Hemolysis initiated by the C3 activator system. N Engl J Med 286:180–184
Hageman GS, Luthert PJ, Chong NHV, Johnson LV, Anderson DH, Mullins RF (2001) An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch’s membrane interface in aging and age-related macular degeneration. Prog Retin Eye Res 20:705–732
Hageman GS, Anderson DH, Johnson LV et al. (2005) A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci USA 102:7227–7232
Haines JL, Hauser MA, Schmidt S et al. (2005) Complement factor H variant increases the risk of age-related macular degeneration. Science 308:419–421
Jozsi M, Manuelian T, Heinen S, Oppermann M, Zipfel PF (2004) Attachment of the soluble complement regulator factor H to cell and tissue surfaces: relevance for pathology. Histol Histopathol 19:251–258
Klein RJ, Zeiss C, Chew EY et al. (2005) Complement factor H polymorphism in age-related macular degeneration. Science 308:385–389
Mullins RF, Russell SR, Anderson DH, Hageman GS (2000) Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease. FASEB J 14:835–846
Nicholson-Weller A, March JP, Rosenfeld SI, Austen KF (1983) Affected erythrocytes of patients with paroxysmal nocturnal hemoglobinuria are deficient in the complement regulatory protein, decay accelerating factor. Proc Natl Acad Sci USA 80:5066–5070
Rodriguez de CS, Esparza-Gordillo J, Goicoechea de JE, Lopez-Trascasa M, Sanchez-Corral P (2004) The human complement factor H: functional roles, genetic variations and disease associations. Mol Immunol 41:355–367
Zareparsi S, Branham KE, Li M et al. (2005) Strong Association of the Y402H Variant in Complement Factor H at 1q32 with Susceptibility to Age-Related Macular Degeneration. Am J Hum Genet 77:149–153
Zipfel PF, Skerka C, Caprioli J, Manuelian T, Neumann HH, Noris M, Remuzzi G (2001) Complement factor H and hemolytic uremic syndrome. Int Immunopharmacol 1:461–468
Interessenkonflikt:
Der korrespondierende Autor versichert, dass keine Verbindungen mit einer Firma, deren Produkt in dem Artikel genannt ist, oder einer Firma, die ein Konkurrenzprodukt vertreibt, bestehen.
Author information
Authors and Affiliations
Corresponding author
Additional information
Unterstützt durch: Europäische Gemeinschaft (EU) FP5, QoL, KA6, Concerted Action QLRT-2001–02494 „PHOTAGE“; EU FP6, Integrated Project „EVI-GENORET“ (LSHG-CT-2005–5120; Vetragsnummer 512036); Deutsche Forschungsgemeinschaft (DFG) Heisenberg-Stipendium SCHO 734/2–1; DFG Ho 1926/1–3; DFG Schwerpunktprogramm Altersabhängige Makuladegeneration“ SPP 1088.
Rights and permissions
About this article
Cite this article
Charbel Issa, P., Scholl, H.P.N., Holz, F.G. et al. Das Komplementsystem und dessen mögliche Beteiligung an der Pathogenese der altersabhängigen Makuladegeneration (AMD). Ophthalmologe 102, 1036–1042 (2005). https://doi.org/10.1007/s00347-005-1269-4
Issue Date:
DOI: https://doi.org/10.1007/s00347-005-1269-4